Alamar Biosciences Inc (ALMR)

$22.00 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 74.21M
Net Income (ttm) -29.82M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -40.18%
Debt to Equity Ratio N/A
Volume 1,069,200
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, tr...

Industry: Medical Devices
Sector: Healthcare
Phone: (510) 626-9888
Fax: (510) 605-5062
Address:
47071 Bayside Parkway, Fremont, United States
notreload_ai
notreload_ai May. 12 at 1:31 PM
$AVEX $ALMR $BRUN $DXCM $BSY -- THE WSJ
0 · Reply
Marmot1
Marmot1 May. 8 at 9:36 PM
$ALMR keep an eye on this company!
0 · Reply
RB212
RB212 Apr. 27 at 9:17 PM
$ALMR currently watching but interested
0 · Reply
Vetiver
Vetiver Apr. 23 at 8:50 AM
$ALMR might start a position here during correction. promising tech.
0 · Reply
Latest News on ALMR
Alamar Biosciences Slides: FY 2026

May 12, 2026, 6:40 PM EDT - 16 days ago

Alamar Biosciences Slides: FY 2026

Alamar Biosciences initiated with an Outperform at Leerink

2026-05-12T17:01:10.000Z - 17 days ago

Alamar Biosciences initiated with an Outperform at Leerink

Alamar Biosciences initiated with a Neutral at BofA

2026-05-12T10:40:44.000Z - 17 days ago

Alamar Biosciences initiated with a Neutral at BofA

Alamar Biosciences initiated with a Buy at TD Cowen

2026-05-12T09:36:32.000Z - 17 days ago

Alamar Biosciences initiated with a Buy at TD Cowen

Alamar Biosciences initiated with an Overweight at JPMorgan

2026-05-12T08:41:24.000Z - 17 days ago

Alamar Biosciences initiated with an Overweight at JPMorgan

Alamar Biosciences initiated with a Buy at Stifel

2026-05-12T08:40:45.000Z - 17 days ago

Alamar Biosciences initiated with a Buy at Stifel

Alamar Biosciences reports Q1 EPS ($1.74) vs. (68c) last year

2026-05-08T18:02:51.000Z - 21 days ago

Alamar Biosciences reports Q1 EPS ($1.74) vs. (68c) last year

Alamar Biosciences Earnings release: Q1 2026

May 8, 2026, 9:30 AM EDT - 21 days ago

Alamar Biosciences Earnings release: Q1 2026

Alamar Biosciences Quarterly report: Q1 2026

May 8, 2026, 9:30 AM EDT - 21 days ago

Alamar Biosciences Quarterly report: Q1 2026

Alamar Biosciences Reports First Quarter 2026 Financial Results

May 8, 2026, 8:00 AM EDT - 21 days ago

Alamar Biosciences Reports First Quarter 2026 Financial Results

Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference

May 5, 2026, 4:05 PM EDT - 23 days ago

Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference

Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026

Apr 30, 2026, 4:05 PM EDT - 4 weeks ago

Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026

Alamar Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Apr 20, 2026, 4:05 PM EDT - 5 weeks ago

Alamar Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ

Apr 20, 2026, 3:09 AM EDT - 5 weeks ago

Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ

Cathie Wood’s ARK Investment buys 537.5K shares of Alamar Biosciences today

2026-04-18T00:10:12.000Z - 5 weeks ago

Cathie Wood’s ARK Investment buys 537.5K shares of Alamar Biosciences today

Alamar Biosciences valued at $1.5 billion as shares jump in Nasdaq debut

Apr 17, 2026, 12:45 PM EDT - 6 weeks ago

Alamar Biosciences valued at $1.5 billion as shares jump in Nasdaq debut

Alamar Biosciences opens at $22.60, IPO priced at $17 per share

2026-04-17T16:35:12.000Z - 6 weeks ago

Alamar Biosciences opens at $22.60, IPO priced at $17 per share

Alamar Biosciences indicated to open at $20, IPO priced at $17

2026-04-17T15:25:11.000Z - 6 weeks ago

Alamar Biosciences indicated to open at $20, IPO priced at $17

Alamar Biosciences 11.25M share IPO priced at $17.00

2026-04-17T10:35:12.000Z - 6 weeks ago

Alamar Biosciences 11.25M share IPO priced at $17.00

Alamar Biosciences Announces Pricing of Upsized Initial Public Offering

Apr 16, 2026, 9:15 PM EDT - 6 weeks ago

Alamar Biosciences Announces Pricing of Upsized Initial Public Offering

Alamar Biosciences Registration statement: Registration filing

Apr 16, 2026, 8:00 AM EDT - 6 weeks ago

Alamar Biosciences Registration statement: Registration filing

Alamar Biosciences Registration statement: Registration filing

Apr 13, 2026, 8:00 AM EDT - 6 weeks ago

Alamar Biosciences Registration statement: Registration filing

Protein biomarker detection platform Alamar Biosciences files for a $100 million IPO

Mar 27, 2026, 5:12 PM EDT - 2 months ago

Protein biomarker detection platform Alamar Biosciences files for a $100 million IPO

Alamar Biosciences IPO Registration Document (S-1)

Mar 27, 2026, 4:12 PM EDT - 2 months ago

Alamar Biosciences IPO Registration Document (S-1)

notreload_ai
notreload_ai May. 12 at 1:31 PM
$AVEX $ALMR $BRUN $DXCM $BSY -- THE WSJ
0 · Reply
Marmot1
Marmot1 May. 8 at 9:36 PM
$ALMR keep an eye on this company!
0 · Reply
RB212
RB212 Apr. 27 at 9:17 PM
$ALMR currently watching but interested
0 · Reply
Vetiver
Vetiver Apr. 23 at 8:50 AM
$ALMR might start a position here during correction. promising tech.
0 · Reply